Gene · 5880
Papers3,143
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,143
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In-depth analysis of prognostic markers associated with the tumor immune microenvironment and genetic mutations in breast cancer based on an NK cell-related risk model. | Heliyon | 2024 | 38226219 | PubTator, text mining | PubMed |
| 5-methylcytosine-mediated upregulation of circular RNA 0102913 augments malignant properties of colorectal cancer cells through a microRNA-571/Rac family small GTPase 2 axis. | Gene | 2024 | 38224924 | PubTator, text mining | PubMed |
| Association Between Diverse Cell Death Patterns Related Gene Signature and Prognosis, Drug Sensitivity, and Immune Microenvironment in Glioblastoma. | J Mol Neurosci | 2024 | 38214842 | PubTator, text mining | PubMed |
| Pulsatilla saponin D regulates ras-related C3 botulinum toxin substrate 3 (RAC3) to overcome resistance to paclitaxel in lung adenocarcinoma cells. | BMC Cancer | 2024 | 38200409 | PubTator, text mining | PubMed |
| Clinical and functional spectrum of RAC2-related immunodeficiency. | Blood | 2024 | 38194689 | PubTator, text mining | PubMed |
| Establishment and characterization of a highly metastatic hepatocellular carcinoma cell line. | Bioengineered | 2024 | 38184822 | PubTator, text mining | PubMed |
| Organogenetic transcriptomes of the Drosophila embryo at single cell resolution. | Development | 2024 | 38174902 | PubTator, text mining | PubMed |
| Leukocyte differential gene expression prognostic value for high versus low seizure frequency in temporal lobe epilepsy. | BMC Neurol | 2024 | 38166692 | PubTator, text mining | PubMed |
| Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. | Biomol Ther (Seoul) | 2024 | 38148558 | PubTator, text mining | PubMed |
| The genetics of Graves' disease. | Rev Endocr Metab Disord | 2024 | 38108994 | PubTator, text mining | PubMed |
| Prognostic value of lncRNA AFAP1-AS1 in breast cancer: a meta-analysis and validated study in Chinese population. | Cancer Rep (Hoboken) | 2024 | 37916733 | PubTator, text mining | PubMed |
| SILAC proteomics based on 3D cell spheroids unveils the role of RAC2 in regulating the crosstalk between triple-negative breast cancer cells and tumor-associated macrophages. | Int J Biol Macromol | 2024 | 37879580 | PubTator, text mining | PubMed |
| WNT Signaling in Stem Cells: A Look into the Non-Canonical Pathway. | Stem Cell Rev Rep | 2024 | 37804416 | PubTator, text mining | PubMed |
| BML-281 promotes neuronal differentiation by modulating Wnt/Ca2+ and Wnt/PCP signaling pathway. | Mol Cell Biochem | 2024 | 37768498 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling. | Mol Cancer Ther | 2024 | 37735104 | PubTator, text mining | PubMed |
| [Endoscopic Findings of Common Gastritis in Koreans]. | Korean J Helicobacter Up Gastrointest Res | 2023 | 40502280 | PubTator, text mining | PubMed |
| A ten long noncoding RNA-based prognostic risk model construction and mechanism study in the basal-like immune-suppressed subtype of triple-negative breast cancer. | Transl Cancer Res | 2023 | 38193005 | PubTator, text mining | PubMed |
| Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children. | Pharmaceutics | 2023 | 38140053 | PubTator, text mining | PubMed |
| Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL). | Genes (Basel) | 2023 | 38137005 | PubTator, text mining | PubMed |
| Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension. | Sci Rep | 2023 | 38110438 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5880/papers?page=7